Loading…

A rash that’s more than skin deep

Discussion Neonatal lupus erythematosus is an acquired disease of the newborn caused by transplacental transfer of maternal anti-Ro/SSA, anti-La/SSB, and anti-U1 RNP antibodies, and has a frequency of 1 in 12500 to 20000 live births. 2 4 The condition might involve (in order of decreasing frequency)...

Full description

Saved in:
Bibliographic Details
Published in:BMJ (Online) 2018-01, Vol.360, p.k8-k8
Main Authors: Chin, Xinyi, Chan, Daisy Kwai Lin, Chong, Jin Ho
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b248t-e97f54d0429339fb0a385e177b397a617cc86dfe96fb7109452f207fa63ead863
cites
container_end_page k8
container_issue
container_start_page k8
container_title BMJ (Online)
container_volume 360
creator Chin, Xinyi
Chan, Daisy Kwai Lin
Chong, Jin Ho
description Discussion Neonatal lupus erythematosus is an acquired disease of the newborn caused by transplacental transfer of maternal anti-Ro/SSA, anti-La/SSB, and anti-U1 RNP antibodies, and has a frequency of 1 in 12500 to 20000 live births. 2 4 The condition might involve (in order of decreasing frequency) the dermatological, cardiac, hepatobiliary, and haematological systems. 2 4 5 6 Cutaneous manifestation is the commonest feature of neonatal lupus erythematosus and can present at birth 5 or within the first 4-6 weeks of life. 7 8 In one study, skin lesions were characterised as erythematous patches (91.7%), lesions resembling subacute cutaneous lupus erythematosus (50%), petechiae (41.7%), persistent cutis marmorata (16.7%), and discoid lesions (8.3%). First and second degree heart block can resolve spontaneously in the first few months of life. 3 Cutaneous lesions are managed with emollients and mild to potent topical corticosteroids if symptoms are severe. Parents should be advised on sun avoidance or the application of sunscreen. 4 The highest incidence of abnormal laboratory results occur when the infant is 3 months old, and most cases resolve by 9 months. 9 These infants should be reviewed over a longer period to observe for future development of rheumatological diseases. 5 8 9 Approximately half of mothers of babies with neonatal lupus erythematosus are asymptomatic at the time of delivery. 3 10 Of these, nearly half of asymptomatic mothers subsequently develop connective tissue disease. [...]they should be screened for auto-antibodies and reviewed for signs and symptoms.
doi_str_mv 10.1136/bmj.k8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1992016397</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1991052219</sourcerecordid><originalsourceid>FETCH-LOGICAL-b248t-e97f54d0429339fb0a385e177b397a617cc86dfe96fb7109452f207fa63ead863</originalsourceid><addsrcrecordid>eNp10E1LwzAcx_EgihtzvgSpDMRLZ_5J83QcwycYeNFzSNuEPbWdSXvw5tvY2_OVmLLpQfAUAp98CT-ELgFPASi_y6v1dCNP0BAE4ylISk_RECumUglUDtA4hDXGmFAhFWfnaEAUFQBCDdFklngTlkm7NO3X5z4kVeNtf6uTsFnVSWnt7gKdObMNdnw8R-jt4f51_pQuXh6f57NFmpNMtqlVwrGsxFmsU-VybKhkFoTIqRKGgygKyUtnFXe5AKwyRhzBwhlOrSklpyN0e-jufPPe2dDqahUKu92a2jZd0KAUwcBjLdLJH7puOl_H3_UKMCMEVFQ3B1X4JgRvnd75VWX8hwas--V0XE5vZIRXx1yXV7b8ZT87RXB9AP2DfyLfJu1xRg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1991052219</pqid></control><display><type>article</type><title>A rash that’s more than skin deep</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>BMJ Publishing</source><creator>Chin, Xinyi ; Chan, Daisy Kwai Lin ; Chong, Jin Ho</creator><creatorcontrib>Chin, Xinyi ; Chan, Daisy Kwai Lin ; Chong, Jin Ho</creatorcontrib><description>Discussion Neonatal lupus erythematosus is an acquired disease of the newborn caused by transplacental transfer of maternal anti-Ro/SSA, anti-La/SSB, and anti-U1 RNP antibodies, and has a frequency of 1 in 12500 to 20000 live births. 2 4 The condition might involve (in order of decreasing frequency) the dermatological, cardiac, hepatobiliary, and haematological systems. 2 4 5 6 Cutaneous manifestation is the commonest feature of neonatal lupus erythematosus and can present at birth 5 or within the first 4-6 weeks of life. 7 8 In one study, skin lesions were characterised as erythematous patches (91.7%), lesions resembling subacute cutaneous lupus erythematosus (50%), petechiae (41.7%), persistent cutis marmorata (16.7%), and discoid lesions (8.3%). First and second degree heart block can resolve spontaneously in the first few months of life. 3 Cutaneous lesions are managed with emollients and mild to potent topical corticosteroids if symptoms are severe. Parents should be advised on sun avoidance or the application of sunscreen. 4 The highest incidence of abnormal laboratory results occur when the infant is 3 months old, and most cases resolve by 9 months. 9 These infants should be reviewed over a longer period to observe for future development of rheumatological diseases. 5 8 9 Approximately half of mothers of babies with neonatal lupus erythematosus are asymptomatic at the time of delivery. 3 10 Of these, nearly half of asymptomatic mothers subsequently develop connective tissue disease. [...]they should be screened for auto-antibodies and reviewed for signs and symptoms.</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.k8</identifier><identifier>PMID: 29371179</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Babies ; Blood tests ; Breasts ; Congenital diseases ; Corticosteroids ; Dermatitis ; Disease ; Exanthema ; Heart ; Hematology ; Immunoglobulins ; Lupus ; Mortality ; Mothers ; Newborn babies ; Patient admissions ; Risk factors</subject><ispartof>BMJ (Online), 2018-01, Vol.360, p.k8-k8</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to</rights><rights>Copyright: 2018 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b248t-e97f54d0429339fb0a385e177b397a617cc86dfe96fb7109452f207fa63ead863</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmj.com/content/360/bmj.k8.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bmj.com/content/360/bmj.k8.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>112,113,314,780,784,3194,27924,27925,77594,77595</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29371179$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chin, Xinyi</creatorcontrib><creatorcontrib>Chan, Daisy Kwai Lin</creatorcontrib><creatorcontrib>Chong, Jin Ho</creatorcontrib><title>A rash that’s more than skin deep</title><title>BMJ (Online)</title><addtitle>BMJ</addtitle><description>Discussion Neonatal lupus erythematosus is an acquired disease of the newborn caused by transplacental transfer of maternal anti-Ro/SSA, anti-La/SSB, and anti-U1 RNP antibodies, and has a frequency of 1 in 12500 to 20000 live births. 2 4 The condition might involve (in order of decreasing frequency) the dermatological, cardiac, hepatobiliary, and haematological systems. 2 4 5 6 Cutaneous manifestation is the commonest feature of neonatal lupus erythematosus and can present at birth 5 or within the first 4-6 weeks of life. 7 8 In one study, skin lesions were characterised as erythematous patches (91.7%), lesions resembling subacute cutaneous lupus erythematosus (50%), petechiae (41.7%), persistent cutis marmorata (16.7%), and discoid lesions (8.3%). First and second degree heart block can resolve spontaneously in the first few months of life. 3 Cutaneous lesions are managed with emollients and mild to potent topical corticosteroids if symptoms are severe. Parents should be advised on sun avoidance or the application of sunscreen. 4 The highest incidence of abnormal laboratory results occur when the infant is 3 months old, and most cases resolve by 9 months. 9 These infants should be reviewed over a longer period to observe for future development of rheumatological diseases. 5 8 9 Approximately half of mothers of babies with neonatal lupus erythematosus are asymptomatic at the time of delivery. 3 10 Of these, nearly half of asymptomatic mothers subsequently develop connective tissue disease. [...]they should be screened for auto-antibodies and reviewed for signs and symptoms.</description><subject>Babies</subject><subject>Blood tests</subject><subject>Breasts</subject><subject>Congenital diseases</subject><subject>Corticosteroids</subject><subject>Dermatitis</subject><subject>Disease</subject><subject>Exanthema</subject><subject>Heart</subject><subject>Hematology</subject><subject>Immunoglobulins</subject><subject>Lupus</subject><subject>Mortality</subject><subject>Mothers</subject><subject>Newborn babies</subject><subject>Patient admissions</subject><subject>Risk factors</subject><issn>0959-8138</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp10E1LwzAcx_EgihtzvgSpDMRLZ_5J83QcwycYeNFzSNuEPbWdSXvw5tvY2_OVmLLpQfAUAp98CT-ELgFPASi_y6v1dCNP0BAE4ylISk_RECumUglUDtA4hDXGmFAhFWfnaEAUFQBCDdFklngTlkm7NO3X5z4kVeNtf6uTsFnVSWnt7gKdObMNdnw8R-jt4f51_pQuXh6f57NFmpNMtqlVwrGsxFmsU-VybKhkFoTIqRKGgygKyUtnFXe5AKwyRhzBwhlOrSklpyN0e-jufPPe2dDqahUKu92a2jZd0KAUwcBjLdLJH7puOl_H3_UKMCMEVFQ3B1X4JgRvnd75VWX8hwas--V0XE5vZIRXx1yXV7b8ZT87RXB9AP2DfyLfJu1xRg</recordid><startdate>20180125</startdate><enddate>20180125</enddate><creator>Chin, Xinyi</creator><creator>Chan, Daisy Kwai Lin</creator><creator>Chong, Jin Ho</creator><general>BMJ Publishing Group LTD</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20180125</creationdate><title>A rash that’s more than skin deep</title><author>Chin, Xinyi ; Chan, Daisy Kwai Lin ; Chong, Jin Ho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b248t-e97f54d0429339fb0a385e177b397a617cc86dfe96fb7109452f207fa63ead863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Babies</topic><topic>Blood tests</topic><topic>Breasts</topic><topic>Congenital diseases</topic><topic>Corticosteroids</topic><topic>Dermatitis</topic><topic>Disease</topic><topic>Exanthema</topic><topic>Heart</topic><topic>Hematology</topic><topic>Immunoglobulins</topic><topic>Lupus</topic><topic>Mortality</topic><topic>Mothers</topic><topic>Newborn babies</topic><topic>Patient admissions</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chin, Xinyi</creatorcontrib><creatorcontrib>Chan, Daisy Kwai Lin</creatorcontrib><creatorcontrib>Chong, Jin Ho</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>BMJ (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chin, Xinyi</au><au>Chan, Daisy Kwai Lin</au><au>Chong, Jin Ho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A rash that’s more than skin deep</atitle><jtitle>BMJ (Online)</jtitle><addtitle>BMJ</addtitle><date>2018-01-25</date><risdate>2018</risdate><volume>360</volume><spage>k8</spage><epage>k8</epage><pages>k8-k8</pages><issn>0959-8138</issn><eissn>1756-1833</eissn><abstract>Discussion Neonatal lupus erythematosus is an acquired disease of the newborn caused by transplacental transfer of maternal anti-Ro/SSA, anti-La/SSB, and anti-U1 RNP antibodies, and has a frequency of 1 in 12500 to 20000 live births. 2 4 The condition might involve (in order of decreasing frequency) the dermatological, cardiac, hepatobiliary, and haematological systems. 2 4 5 6 Cutaneous manifestation is the commonest feature of neonatal lupus erythematosus and can present at birth 5 or within the first 4-6 weeks of life. 7 8 In one study, skin lesions were characterised as erythematous patches (91.7%), lesions resembling subacute cutaneous lupus erythematosus (50%), petechiae (41.7%), persistent cutis marmorata (16.7%), and discoid lesions (8.3%). First and second degree heart block can resolve spontaneously in the first few months of life. 3 Cutaneous lesions are managed with emollients and mild to potent topical corticosteroids if symptoms are severe. Parents should be advised on sun avoidance or the application of sunscreen. 4 The highest incidence of abnormal laboratory results occur when the infant is 3 months old, and most cases resolve by 9 months. 9 These infants should be reviewed over a longer period to observe for future development of rheumatological diseases. 5 8 9 Approximately half of mothers of babies with neonatal lupus erythematosus are asymptomatic at the time of delivery. 3 10 Of these, nearly half of asymptomatic mothers subsequently develop connective tissue disease. [...]they should be screened for auto-antibodies and reviewed for signs and symptoms.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>29371179</pmid><doi>10.1136/bmj.k8</doi></addata></record>
fulltext fulltext
identifier ISSN: 0959-8138
ispartof BMJ (Online), 2018-01, Vol.360, p.k8-k8
issn 0959-8138
1756-1833
language eng
recordid cdi_proquest_miscellaneous_1992016397
source JSTOR Archival Journals and Primary Sources Collection; BMJ Publishing
subjects Babies
Blood tests
Breasts
Congenital diseases
Corticosteroids
Dermatitis
Disease
Exanthema
Heart
Hematology
Immunoglobulins
Lupus
Mortality
Mothers
Newborn babies
Patient admissions
Risk factors
title A rash that’s more than skin deep
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T15%3A34%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20rash%20that%E2%80%99s%20more%20than%20skin%20deep&rft.jtitle=BMJ%20(Online)&rft.au=Chin,%20Xinyi&rft.date=2018-01-25&rft.volume=360&rft.spage=k8&rft.epage=k8&rft.pages=k8-k8&rft.issn=0959-8138&rft.eissn=1756-1833&rft_id=info:doi/10.1136/bmj.k8&rft_dat=%3Cproquest_cross%3E1991052219%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b248t-e97f54d0429339fb0a385e177b397a617cc86dfe96fb7109452f207fa63ead863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1991052219&rft_id=info:pmid/29371179&rfr_iscdi=true